Abstract: The present invention provides therapeutic formulations for solutions of .DELTA..sup.9 -tetrahydrocannabinol to be delivered by metered dose inhalers. The formulations, which utilize non-CFC propellants, provide a stable aerosol-deliverable source of .DELTA.. U.S. Patents via NewsEdge Corporation : Abstract: The present invention provides therapeutic formulations for solutions of .DELTA..sup.9 -tetrahydrocannabinol (.DELTA..sup.9 THC) to be delivered by metered dose inhalers. The formulations, which utilize non-CFC propellants, provide a stable aerosol-deliverable source of .DELTA..sup.9 THC for the treatment of various medical conditions, such as: nausea and vomiting associated with chemotherapy; muscle spasticity; pain; anorexia associated with AIDS wasting syndrome; epilepsy; glaucoma; bronchial asthma; and mood disorders. Ex Claim Text: A pharmaceutical composition consisting essentially of 1,1,1,2,3,3,3-heptafluoropropane (HFA 227), .DELTA..sup.9 -tetrahydrocannabinol, and up to 15 percent by weight of an organic solvent, said .DELTA..sup.9 -tetrahydrocannabinol and said organic solvent being dissolved in said HFA 227 to form a stable composition, wherein said .DELTA..sup.9 -tetrahydrocannabinol is present in said composition in concentrations ranging from 0.147% w/w (.+-.0.008) to 5.940% w/w (.+-.0.191). Patent Number: 6509005 Issue Date: 2003 01 21 If you would like to purchase a copy of this patent, please call MicroPatent at 800-648-6787. Inventor(s): Peart, Joanne Byron, Peter R. Lichtman, Aron H. Martin, Billy R. << Copyright ©2003 MicroPatent >>
VII Российский конгресс с международным участием «Молекулярные основы клинической медицины – возможное и реальное» пройдет в Санкт-Петербурге 16 декабря, 2024
Ведущий научный сотрудник НЦПЗ Ирина Федоровна Рощина награждена медалью Г.И. Челпанова 10 декабря, 2024